MTP Session XX: CT | Late and Rare Complications of Immune Effector Cell Therapies

Session Chair: Frederick Locke, MD

• IEC-HS | William Johnson, DO | Memorial Sloan Kettering Cancer Center, New York, New York, USA

• Emerging Toxicities of CAR-T | Frederick Locke, MD | H. Lee Moffitt Cancer Center, Tampa, Florida, USA

• Beyond CRS and ICANS: Mortality-Defining and Non-Canonical Toxicities of CAR T-Cell Therapy | Kai Rejeski, MD, MHBA | LMU University Hospital, Munich, Germany